2-(Trifluoromethyl)benzenesulfonamide, 98.0%, 100g

4-(1H-Pyrazol-4-yl)-butyric acid, 95.0%, 1g

3-Bromo-7-methyl-1H-pyrrolo[2,3-c]pyridine, 98+%, 250mg

[2-(4-Ethylpiperazin-1-yl)phenyl]methanol, 95.0%, 10g

2-Chloro-1-[2-(2,3-dihydro-1,4-benzodioxin-6-yl)pyrrolidin-1-yl]ethan-1-one, 97%, 250mg

2-(3-Fluorophenyl)-2-oxoacetaldehyde, 97%, 1g

4-Bromo-2-chloro-1-methoxybenzene, 98.0%, 500g

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 25g

6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxylic acid, 95.0%, 500mg

1-Benzyl-2-phenyl-1H-imidazole>95.0%(GC)5g

2-Cyclobutyl-1,3-thiazole-5-carbaldehyde, 98%, 1g

Puntas de pipeta Mμlti® de largo alcance 0,1-10 μl, estándar, caja, no estéril, 960 piezas

2,4-DICHLORO-7-(PHENYLSULFONYL)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID METHYL ESTER, 95.0%, 1g